Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats

No abstract is available for this paper.

• Publication year

  2014

• Venue

  European journal of drug metabolism and pharmacokinetics

• Publication date

  2014-05-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s13318-014-0203-zPMID 24871039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models

  2013cited by this paper
• Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models

  2013cited by this paper
• Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity.

  2010cited by this paper
• Apigenin protects endothelium-dependent relaxation of rat aorta against oxidative stress.

  2009cited by this paper
• Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.

  2009cited by this paper
• Hypersensitivity reactions to antineoplastic agents: an overview

  2009cited by this paper
• Apigenin suppresses insulin‐like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study

  2009cited by this paper
• Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.

  2009cited by this paper
• Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats.

  2008cited by this paper
• Anti-asthmatic action of quercetin and rutin in conscious guinea-pigs challenged with aerosolized ovalbumin

  2007cited by this paper
• Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.

  2007cited by this paper
• Effects of morin on the pharmacokinetics of etoposide in rats.

  2007cited by this paper
• Role of P-Glycoprotein Inhibition for Drug Interactions

  2007cited by this paper
• Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues

  2006cited by this paper
• Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.

  2006cited by this paper
• Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells

  2006cited by this paper
• Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.

  2005cited by this paper
• Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways

  2005cited by this paper
• Pharmacokinetic and pharmacodynamic interactions of morin and cyclosporin.

  2005cited by this paper
• The effect of verapamil on the pharmacokinetics of paclitaxel in rats.

  2005cited by this paper
• Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells.

  2004cited by this paper
• Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats.

  2004cited by this paper
• Enhanced Oral Bioavailability of Paclitaxel by Coadministration of the P-Glycoprotein Inhibitor KR30031

  2004cited by this paper
• Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats.

  2004cited by this paper
• Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay.

  2003cited by this paper
• Effect of flavonoids on MRP1-mediated transport in Panc-1 cells.

  2003cited by this paper
• Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450.

  2002cited by this paper
• A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel

  2001cited by this paper
• Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.

  2001cited by this paper
• Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions.

  2000cited by this paper
• Oral chemotherapy: rationale and future directions.

  1998cited by this paper
• Co-administration of cyclosporin enables oral therapy with paclitaxel.

  1998cited by this paper
• Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.

  1998cited by this paper
• Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.

  1997influential reference
• Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

  1997cited by this paper
• Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction.

  1997cited by this paper
• Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancer.

  1995cited by this paper
• Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.

  1994cited by this paper
• Clinical toxicities encountered with paclitaxel (Taxol).

  1993cited by this paper
• Inhibition of protein-tyrosine kinase activity by flavanoids and related compounds.

  1989cited by this paper

• From gut to brain: formulation and transporter-guided approaches to maximise rutin central nervous system delivery.

  2026cites this paper
• Potential Alteration of Rifampicin's Bioavailability by Phyllanthus niruri Supplementation in Tuberculosis Therapy.

  2025cites this paper
• Spectroscopic investigation of the competitive-allosteric-synergistic mechanism in the binding of benazepril/apigenin to bovine serum albumin.

  2025cites this paper
• Attenuation of Paclitaxel-induced toxicities by polyphenolic natural compound rutin through inhibition of apoptosis and activation of NRF2/ARE signaling pathways.

  2025cites this paper
• Much More than Nutrients: The Protective Effects of Nutraceuticals on the Blood–Brain Barrier in Diseases

  2025cites this paper
• Rutin: a pain-relieving flavonoid

  2025cites this paper
• An Overview of Biosynthetic Pathway and Therapeutic Potential of Rutin.

  2023cites this paper
• Phytotherapeutic Potential of Rutin Against Xenobiotic-Induced Toxicities in Preclinical Models

  2023cites this paper
• A computational-based approach to fabricate Ceritinib co-amorphous system using a novel co-former Rutin for bioavailability enhancement.

  2023cites this paper
• Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism

  2023cites this paper
• A Neuroprotective Action of Quercetin and Apigenin through Inhibiting Aggregation of Aβ and Activation of TRKB Signaling in a Cellular Experiment

  2023cites this paper
• Phytochemicals That Interfere With Drug Metabolism and Transport, Modifying Plasma Concentration in Humans and Animals

  2022cites this paper
• Interaction Characterization of a Tyrosine Kinase Inhibitor Erlotinib with a Model Transport Protein in the Presence of Quercetin: A Drug–Protein and Drug–Drug Interaction Investigation Using Multi-Spectroscopic and Computational Approaches

  2022cites this paper
• Mechanism of Interactions of dsDNA Binding with Apigenin and Its Sulfamate Derivatives Using Multispectroscopic, Voltammetric, and Molecular Docking Studies

  2021cites this paper
• Herb–drug interaction studies of ethanolic extract of Cassia occidentalis L. coadministered with acetaminophen, theophylline, omeprazole, methotrexate and methylprednisolone

  2021cites this paper
• In vitro and in vivo synergistic interactions between the flavonoid rutin with paracetamol and non-steroidal anti-inflammatory drugs.

  2021cites this paper
• Drug metabolism and pharmacokinetic diversity of Taxus medicinal compounds

  2021cites this paper
• Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers?

  2021cites this paper
• Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition.

  2021cites this paper
• The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors

  2021cites this paper
• Chemoprotective and chemosensitizing effects of apigenin on cancer therapy

  2021cites this paper
• The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives

  2020cites this paper
• Flavonoid-Mediated Modulation of CYP3A Enzyme and P-Glycoprotein Transporter: Potential Effects on Bioavailability and Disposition of Tyrosine Kinase Inhibitors

  2020cites this paper
• Influence of antioxidant flavonoids quercetin and rutin on the in-vitro binding of neratinib to human serum albumin.

  2020cites this paper
• Influence of quercetin and chrysin on the intestinal permeability of paclitaxel, a substrate of P-glycoprotein and CYP3A4 using in vitro rat gut sacs

  2019cites this paper
• Apigenin: A dietary flavonoid with diverse anticancer properties.

  2018cites this paper
• Drug-Drug Interactions: Influence of verapamil on the pharmacokinetics of sitagliptin in rats and Ex vivo models

  2018cites this paper
• Comparative pharmacokinetic profiles of selected irreversible tyrosine kinase inhibitors, neratinib and pelitinib, with apigenin in rat plasma by UPLC–MS/MS

  2017cites this paper
• The therapeutic effects of apigenin and dexamethasone on 5-fluorouracil-induced oral mucositis - a pilot study using a Syrian hamster model.

  2017cites this paper
• Dietary polyphenols influence antimetabolite agents: methotrexate, 6-mercaptopurine and 5-fluorouracil in leukemia cell lines

  2017cites this paper
• Old and new oral anticoagulants: Food, herbal medicines and drug interactions.

  2017cites this paper
• Enhanced oral bioavailability of docetaxel in rats combined with myricetin: In situ and in vivo evidences

  2017cites this paper
• Natural Polyphenols and Terpenoids for Depression Treatment: Current Status

  2017cites this paper
• The therapeutic effects of apigenin and dexamethasone on 5-fluorouracil-induced oral mucositis – a pilot study using a Syrian hamster model

  2017cites this paper
• Pharmacokinetic properties and drug interactions of apigenin, a natural flavone

  2017cites this paper
• The Pharmacological Potential of Rutin

  2016cites this paper
• Effect of HM30181 mesylate salt-loaded microcapsules on the oral absorption of paclitaxel as a novel P-glycoprotein inhibitor.

  2016cites this paper
• Effects of Jia-Wei-Xiao-Yao-San on the Peripheral and Lymphatic Pharmacokinetics of Paclitaxel in Rats

  2016cites this paper
• Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban

  2015cites this paper
• Interactions between CYP3A4 and Dietary Polyphenols

  2015cites this paper